Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 6/1998

01-12-1998 | Review Article

Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

A Comparison of Tolerability and Pharmacology

Authors: Professor Agneta Nordberg, Anne-Lie Svensson

Published in: Drug Safety | Issue 6/1998

Login to get access
Metadata
Title
Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
A Comparison of Tolerability and Pharmacology
Authors
Professor Agneta Nordberg
Anne-Lie Svensson
Publication date
01-12-1998
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 6/1998
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199819060-00004

Other articles of this Issue 6/1998

Drug Safety 6/1998 Go to the issue

Review Article

Treatment of Concomitant Illneses in Patients Receiving Anticonvulsants

Review Article

Peripheral Neuropathy with Nucleoside Antiretrovirals

Review Article

Measles Vaccines

Review Article

Risk of Adverse Events with the Use of Augmentation Therapy for the Treatment of Resistant Depression

Current Opinion

Nonsteroidal Anti-Inflammatory Drugs and Cognitive Function